We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Orchid Cellmark Awarded Forensic DNA Contracts

By Labmedica staff writers
Posted on 11 Oct 2006
Orchid Cellmark Inc., a provider of identity DNA testing services, has announced that its UK operation, Orchid Cellmark Ltd., (Abingdon, UK), has been awarded new DNA contracts with police forces in Kent, Sussex, and London.

Orchid Cellmark was awarded a three-year exclusive contract to provide DNA testing for PACE (Police and Criminal Evidence Act) and crime scene stain-profiling services for Kent and Sussex police forces. More...
There is an option to extend the contract for an additional two years. The company will also provide DNA testing services for PACE mouth swab samples for police in London. The contract is for five years.

The crime scene stain service provided to Kent and Sussex police forces involves the DNA analysis of items recovered from crimes such as burglary and car theft. There are usually no suspects in these cases and any resulting profiles are submitted to the UK National DNA Database for intelligence purposes. The shorter the time interval between the offense date and provision of intelligence from the UK National DNA Database, the greater the chance of police recovering property belonging to a complainant for offenses such as burglary.

The UK operation of Orchid Cellmark provides British customers with a full range of forensic DNA services. From the routine testing of DNA samples for submission to the National DNA Database to the collection and analysis of evidence for the investigation of the most serious crimes, Orchid Cellmark is capable of attaining results from particularly small and compromised samples. The company currently provides most of its forensic DNA services in the United Kingdom through a subcontract relationship with Forensic Alliance Ltd. This relationship is being terminated and the company is now providing its services directly to UK police forces.

Thomas Bologna, president and CEO of Orchid Cellmark Inc., commented, "We believe our DNA forensic operations in the UK are second to none in providing innovation, quality, and rapid testing turnaround time, and we are very pleased that these three important police forces have awarded contracts to Orchid Cellmark. Equally important, we believe that obtaining this business suggests that our plan to provide forensic services directly to UK police forces is proceeding well.”



Related Links:
Orchid Cellmark

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
Gold Member
Latex Test
SLE-Latex Test
New
PBC Assay
Primary Biliary Cholangitis Assays
New
Blood Culture Control Panel
Gram-Negative Blood Culture Control Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Molecular Diagnostics

view channel
Image: The new study findings emphasize the need for incorporating disease heterogeneity into type 2 diabetes care strategies (Photo courtesy of Cell 2025; doi.org/10.1016/j.cell.2025.05.00)

Molecular Fingerprint for Insulin Sensitivity Could Diagnose Diabetes Before Disease Develops

Insulin is a hormone essential for regulating blood sugar levels, and its dysfunction is a key factor in the development of diabetes. Insulin resistance, a condition where the body's cells do not respond... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Custom hardware and software for the real-time detection of immune cell biophysical signatures in NICU (Photo courtesy of Pediatric Research, DOI:10.1038/s41390-025-03952-y)

First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop

Premature infants are highly susceptible to severe and life-threatening conditions, such as sepsis and necrotizing enterocolitis (NEC). Newborn sepsis, which is a bloodstream infection occurring in the... Read more

Pathology

view channel
Image: Results of AI-based 3D virtual H&E staining and quantitative analysis of pathological tissue (Photo courtesy of Nature Communications, DOI:10.1038/s41467-025-59820-0)

Virtual Staining Technology Paves Way for Non-Invasive Pathological Diagnosis

For more than 200 years, traditional pathology has depended on the technique of examining cancer tissues under a microscope, a method that provides only limited, specific cross-sections of the 3D structure... Read more

Technology

view channel
Image: Concept of biosensor integrated into hygiene pads enabling direct semi-quantitative analysis of biomarkers in unprocessed menstruation blood (Photo courtesy of Dosnon, L et al. DOI: 10.1002/advs.202505170)

First Ever Technology Recognizes Disease Biomarkers Directly in Menstrual Blood in Sanitary Towels

Over 1.8 billion people menstruate worldwide, yet menstrual blood has been largely overlooked in medical practice. This blood contains hundreds of proteins, many of which correlate with their concentration... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.